Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. - Wikidata - awgldk - TriplyDB

Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.

Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.

http://www.wikidata.org/entity/Q36646418

about

Management of cardiovascular complications in systemic lupus erythematosus.Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.Endothelial dysfunction in chronic inflammatory diseases Microcirculation as determined by iontophoresis in SLE-patients and controls.Endothelial nitric oxide synthase reduces crescentic and necrotic glomerular lesions, reactive oxygen production, and MCP1 production in murine lupus nephritis Imaging of cardiovascular complications in patients with systemic lupus erythematosus.The Effects of Tetrahydro-iso-alpha Acids and Niacin on Monocyte-Edothelial Cell Interactions and Flow-mediated Vasodilation.NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis.Endothelial function in children with a history of henoch schonlein purpura Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.Cardiovascular benefits of habitual exercise in systemic lupus erythematosus: a review.Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Relationship between endothelial dysfunction and microalbuminuria in familial Mediterranean fever.Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression.Increased pulse wave velocity and carotid intima-media thickness in patients with ulcerative colitis.Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus.Effect of ezetimibe plus pravastatin on endothelial dysfunction in patients with systemic lupus erythematosus.Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus

P2860

Q33730536-C88C6848-2DB2-4D8A-8158-005A2433D17F Q34027430-FDD2BC9D-9D0C-4DD3-984E-8CED4D7FA8D7 Q34072179-5B88FB8C-0438-4B72-A32A-749FD6C2DE66 Q34194913-77AD178D-AC0C-4421-8959-03F321756639 Q34760611-3BCEE41E-1878-4575-A83E-0942F76CA90E Q36052795-9DB1EE1D-BCB3-4A02-834D-9B05FD0854BD Q37323896-298EB1D2-8A0A-4029-ABCF-30A3776746FA Q37341275-0FD46C92-574B-418B-817F-75526301C171 Q37587183-CB1D5F3A-B6A2-44DF-A3ED-759613398F02 Q37699812-BC789445-C85F-48EF-9A1B-2C9D065DE9CD Q38092982-96A143EB-B61F-49D3-B363-AEF5A141E417 Q38162490-C7797485-9A70-402C-BAE1-D65DBD7F4451 Q40086213-E08F1CA9-2957-4A1C-A2BB-7A13FC065B0D Q41260389-8C8127CF-CF13-44DE-839A-50880071C9EA Q42270428-3F3CC0F9-0830-4D72-B5FA-0BFF777A8B97 Q44897123-3DCDB771-0A08-4409-8F8F-B16A4F524B50 Q50228698-D2496C80-935A-4FA3-93DC-4FF1B648FA1E Q50950582-0D0966A1-1053-480B-B188-F7EE8C7906DA Q51550154-193DFD68-649F-4471-BDB6-DA2E3B658055 Q58190241-AE9DCED9-5631-4F2D-A4C6-7AC2580D9BC5

P2860

Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.

http://www.wikidata.org/entity/Q36646418

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Reduced flow-mediated vasodila ...... mplications in lupus patients.

@ast

Reduced flow-mediated vasodila ...... mplications in lupus patients.

@en

type

label

Reduced flow-mediated vasodila ...... mplications in lupus patients.

@ast

Reduced flow-mediated vasodila ...... mplications in lupus patients.

@en

prefLabel

Reduced flow-mediated vasodila ...... mplications in lupus patients.

@ast

Reduced flow-mediated vasodila ...... mplications in lupus patients.

@en

P1433

Q36646418-1F6AD336-11BE-43E2-A1F3-A19DABBB036C

P1476

Q36646418-2309A772-ECAD-41B9-BD24-D30CF665ABBA

P2093

Q36646418-136146B8-8509-4F12-B7CC-A2233BCFF4A2

Q36646418-2BFD0A16-BCA7-48F7-B486-194099878E0A

Q36646418-3CD83E7A-4EAA-41D8-A5AD-6D441CE1EF81

Q36646418-76F37FB0-D3F6-4C2D-ADE3-A474E6A93E9F

Q36646418-95B3D717-2228-4043-88EE-5CE544CBCE84

Q36646418-A6790F69-7DB7-410C-AD55-1BC480B7A5C3

Q36646418-C84D8F61-78FD-42A7-8C37-8EDC0D6262F8

P304

Q36646418-49EADADB-0B8D-42E7-93DB-1F619CBFD260

P31

Q36646418-E3EFBC5B-892C-434C-94DB-D84A7F31AF78

P356

Q36646418-DAD86F9E-9CBE-42EF-9095-E8920FA913C0

P433

Q36646418-5A0AB563-7B83-4379-BF8E-2A8FDBCA0CF2

P478

Q36646418-CD09FC3A-313F-4BD2-8B6E-9357C531F2FA

P50

Q36646418-6890EFB7-0A9C-41A3-99C6-AA0A0D6BFF8F

P577

Q36646418-62153A65-CB62-4695-AE38-617DE20D3014

P698

Q36646418-05389172-D0D4-4001-BBE8-5FC406CB7E7B

P356

J.JAUT.2006.09.008

P1433

Journal of Autoimmunity

P1476

Reduced flow-mediated vasodila ...... mplications in lupus patients.

@en

P2093

Emese Kiss

http://www.w3.org/2001/XMLSchema#string

Gyula Szegedi

http://www.w3.org/2001/XMLSchema#string

Harjit Bhattoa

http://www.w3.org/2001/XMLSchema#string

Henrietta Der

http://www.w3.org/2001/XMLSchema#string

Pal Soltesz

http://www.w3.org/2001/XMLSchema#string

Tunde Tarr

http://www.w3.org/2001/XMLSchema#string

Zsolt Kocsis

http://www.w3.org/2001/XMLSchema#string

P304

211-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAUT.2006.09.008

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Yehuda Shoenfeld

P577

2006-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17088047

http://www.w3.org/2001/XMLSchema#string